nanomaterials Review Electrospinning Nanofibers for Therapeutics Delivery S. M. Shatil Shahriar 1,†, Jagannath Mondal 2,†, Mohammad Nazmul Hasan 2, Vishnu Revuri 2, Dong Yun Lee 3,* and Yong-Kyu Lee 1,2,* 1 Department of Chemical and Biological Engineering, Korea National University of Transportation, Chungju 27469, Korea;
[email protected] 2 Department of Green Bio Engineering, Korea National University of Transportation, Chungju 27469, Korea;
[email protected] (J.M.);
[email protected] (M.N.H.);
[email protected] (V.R.) 3 Department of Bioengineering, College of Engineering, and BK21 PLUS Future Biopharmaceutical Human Resources Training and Research Team, and Institute of Nano Science & Technology (INST), Hanyang University, Seoul 04763, Korea * Correspondence:
[email protected] (D.Y.L.);
[email protected] (Y.-K.L.) † These authors contributed equally to this work. Received: 20 February 2019; Accepted: 22 March 2019; Published: 3 April 2019 Abstract: The limitations of conventional therapeutic drugs necessitate the importance of developing novel therapeutics to treat diverse diseases. Conventional drugs have poor blood circulation time and are not stable or compatible with the biological system. Nanomaterials, with their exceptional structural properties, have gained significance as promising materials for the development of novel therapeutics. Nanofibers with unique physiochemical and biological properties have gained significant attention in the field of health care and biomedical research. The choice of a wide variety of materials for nanofiber fabrication, along with the release of therapeutic payload in sustained and controlled release patterns, make nanofibers an ideal material for drug delivery research. Electrospinning is the conventional method for fabricating nanofibers with different morphologies and is often used for the mass production of nanofibers.